Skip to content

Eda Zhuleku



Zhuleku Eda
Eda Zhuleku



Eda is a life sciences specialist lawyer with more than nine years’ experience in the sector.

Eda is an expert with respect to all regulatory issues that may be of interest to pharma, medical device; IVDs and life science businesses, including (early) benefit assessment, market access strategies, prescription of drugs and medical devices and eligibility for reimbursement. Further, she assists in every stage of the product life-cycle and advises pharma businesses, medical device and other life sciences businesses on challenges in terms of reimbursement and social law.

News & insights

Multiple test tubes and dropper

Blog Post: 13 AUGUST 2021

EU Clinical Trial Regulation to Take Effect on 31 January 2022

The European Commission has announced that the Clinical Trials Regulation, already enacted in 2014, will take effect on 31 January 2022.

Read more
close up of glaze building

Publications: 08 JULY 2021

Innovation and search for growth spark MedTech rebound

The postponement of non-urgent medical procedures in the early days of the Covid-19 pandemic led to a lull in MedTech transaction activity in the first half of 2020 but makers of medical devices…

Read more

Publications: 19 APRIL 2021

SARS-CoV-2 Occupational Health and Safety Regulation: Mandatory testing offer

After weeks of tough wrangling, the Federal Cabinet has decided to oblige companies throughout Germany to offer coronavirus tests to their employees. This obligation will be included in the SARS-CoV-2…

Read more
Allen & Overy graphic

Publications: 24 JUNE 2020

Covid-19 coronavirus: How the global life sciences sector is responding to the pandemic

Our life sciences sector team reviews the steps taken by the industry and public bodies to minimise disruption to regular business activities and to promote the development and supply of medicines and…

Read more



Corporate and M&A


Life Sciences



Allen & Overy LLP
Maximilianstraße 35
80539 Munich

View office →



Certified Lawyer for Life Sciences since 2018

Pro-bono experience

  • Eda is a member of the Pro Bono Steering Committee in Germany

Published work

  • Zhuleku E. (2020) “Covid-19 and the Life Science Sector „Covid-19 and the Life Science Sector”, Practical Law ‐ London, Thomson Reuters
  • Zhuleku E, Professor Ehlers A, (2018) „Neues Bundesdatenschutzgesetz und EU‐Datenschutzverordnung Anpassungsbedarf bei den Unternehmen“ in pharmind Nr. 1, 82 , Edition Cantor Verlag
  • Zhuleku E, Professor Ehlers A, (2016) „Die FSA‐Kodizes und ihre Durchsetzung – wie konsequent ist das“ in: pharmind Nr. 6, 869, Edition Cantor Verlag
  • Zhuleku E, (2014) Die ärztliche Aufklärungspflicht nach dem Patientenrechtegesetz“ in: Der Diabetologe, Springer Medizin
  • Zhuleku E, (2013) „Rechtliche Stolpersteine des Bestandsmarktaufrufs“ in Highlights Magazin Ausgabe 8/13, Lehr & Visarius Verlag GmbH